Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abametapir Lotion 0.74% for Head Lice Infestation
NCT02062060Phase 3Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Feb 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pediculosis capitis comparing Abametapir Lotion with Vehicle Lotion (2 arms). Primary endpoint: Proportion of index subjects who are lice-free at all follow-up visits through to the Day 14 visit. Started Feb 2014; status: completed.
02
Drugs
abametapir
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT02062060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062060.